Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,365,368
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
11,137,806
-
Shares change
-
+302,035
-
Total reported value, excl. options
-
$162,244,000
-
Value change
-
+$3,974,891
-
Number of buys
-
21
-
Number of sells
-
-15
-
Price
-
$14.57
Significant Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q3 2015
42 filings reported holding PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share as of Q3 2015.
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,137,806 shares
of 105,365,368 outstanding shares and own 11% of the company stock.
Largest 10 shareholders include FMR LLC (2,259,801 shares), ORBIMED ADVISORS LLC (1,841,400 shares), BAKER BROS. ADVISORS LP (988,299 shares), JENNISON ASSOCIATES LLC (968,755 shares), MILLENNIUM MANAGEMENT LLC (801,493 shares), JANUS CAPITAL MANAGEMENT LLC (771,812 shares), Redmile Group, LLC (660,816 shares), Viking Global Investors LP (576,632 shares), Clearbridge Investments, LLC (498,559 shares), and HIGHLAND CAPITAL MANAGEMENT LP (395,057 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.